In an in‐vitro model using human fetal membranes, 17‐&agr; hydroxyprogesterone caproate is not an optimal progestogen for inhibition of fetal membrane weakening
Sign Up to like & getrecommendations! Published in 2017 at "American Journal of Obstetrics and Gynecology"
DOI: 10.1016/j.ajog.2017.10.004
Abstract: Background The progestogen 17‐&agr; hydroxyprogesterone caproate (17‐OHPC) is 1 of only 2 agents recommended for clinical use in the prevention of spontaneous preterm delivery, and studies of its efficacy have been conflicting. We have developed… read more here.
Keywords: fetal membrane; hydroxyprogesterone caproate; factor; membrane weakening ... See more keywords